How a Compact NGS Sequencer Removes the Bottleneck in Clinical Genomics

GS100 Desktop DNA Sequencing System | High-Throughput NGS Sequencer for Precision Genomics

Next-generation sequencing has long been constrained by batching. Labs accumulate samples to justify a run, delaying results and complicating workflow scheduling. The GS100 enters this gap with a flexible run start that eliminates the batching requirement entirely.

The system delivers Q40-level accuracy—>85% of bases exceed this threshold—making it viable for low-frequency mutation detection in oncology and prenatal screening. Turnaround for a single-end 50-base read is as fast as 6.5 hours, compressing the gap between sample receipt and clinical decision.

Output ranges from 25 million to 100 million reads per run, covering applications from whole exome sequencing to metagenomic pathogen detection. The platform accepts standard library prep protocols, reducing the need for proprietary consumables or workflow retraining.

For laboratories scaling precision medicine services, the GS100 represents a shift toward on-demand sequencing capacity. It collapses the trade-off between throughput and latency that has historically forced labs to choose between cost efficiency and clinical responsiveness.

China’s sequencing instrument ecosystem has matured rapidly. Systems like this one allow domestic manufacturers to bypass the service-lab model entirely, placing sequencing capability directly into hospital and research workflows.

The GS100 is a tool for operational logic as much as genomic analysis. It suggests that the next frontier in NGS is not higher throughput, but lower friction.

Why it matters:
Labs evaluating NGS platforms often underestimate the cost of workflow inflexibility. The GS100 addresses this directly—no batching, faster turnaround, lower per-sample overhead for variable volume workflows.

View Product →